Table 3

Distribution and incidence densities of 263 HAI

Kind of healthcare-associated infection (HAI)
No. (Proportion)
ID

All HAIs
263 (100%)
4.80
Bloodstream infections (BSI)
153 (58%)
2.79
     Laboratory-confirmed (blood-culture positive) BSI
138 (52%)
2.52
          Bacteremia
95 (36%)
1.73
          Sepsis
35 (13%)
0.64
          Septic shock
5 (2%)
0.09
          Septic shock with multiorgan failure
3 (1%)
0.05
     Blood-culture negative BSI
15 (6%)
0.27
          Clinically defined sepsis
10 (4%)
0.18
          Clinically defined septic shock
1 (0%)
0.02
          Clinically defined septic shock with multiorgan failure
4 (2%)
0.07
Radiologically confirmed pneumonia
20 (8%)
0.36
Invasive aspergillosis
26 (10%)
0.47
     Pulmonary invasive aspergillosis
21 (8%)
0.38
          Proven pulmonary case of invasive aspergillosis
6 (2%)
0.11
          Probable pulmonary case of invasive aspergillosis
15 (6%)
0.27
     Other localization (sinus, central nervous system)
5 (2%)
0.09
Respiratory syncytial virus (RSV) infection
2 (1%)
0.04
Surgical site infection
15 (6%)
0.27
     Early (≤ 14 days from intervention) surgical site infection
6 (2%)
0.11
     Late (> 14 days from intervention) surgical site infection
9 (3%)
0.16
Clostridium difficileassociated enterocolitis
24 (9%)
0.44
     Preceding i.v. antibiotics within 14 days
11 (4%)
0.20
     No preceding i.v. antibiotics within 14 days
13 (5%)
0.24
Rotavirus associated enterocolitis
6 (2%)
0.11
Urinary tract infection (UTI)
8 (3%)
0.15
     UTI related to urinary tract catheter
3 (1%)
0.05
     UTI not related to urinary tract catheter
5 (2%)
0.09
Ventriculitis related to external CSF drainage
1 (0%)
0.02
Local infections at the central venous access device exit site
8 (3%)
0.15

No. indicates the absolute number; ID indicates incidence density per 1,000 inpatient days

Simon et al. BMC Infectious Diseases 2008 8:70   doi:10.1186/1471-2334-8-70